JOSHOA A KAZAM Insider Trading $KITE Kite Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSHOA A KAZAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSHOA A KAZAM. JOSHOA A KAZAM is Director in TG THERAPEUTICS, INC. ($TGTX) and Director in CAPRICOR THERAPEUTICS, INC. ($CAPR) and Director in Kite Pharma, Inc. ($KITE) and Director in Platinum Eagle Acquisition Corp. ($EAGL) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON) and Director in Diamond Eagle Acquisition Corp. \ DE ($DEAC).
JOSHOA A KAZAM in Kite Pharma, Inc.
Trading Symbol: KITEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOSHOA A KAZAM: Director
Holdings: 70,050 shares
Current Value: $3,735,066
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOSHOA A KAZAM in Kite Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLO, CAPR, DKNG, KITE, KRON, EAGL, TGTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 1.35 | 50,000 | 67,500 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Sell | U | 180.00 | 2,553 | 459,540 | 1,807 | 4.4 K to 1.8 K (-58.56 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Sell | D | 180.00 | 70,050 | 12,609,000 | 0 | 70.1 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Buy | J | 0.00 | 70,050 | 0 | 70,050 | 0 to 70.1 K |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Grant | A | 0.00 | 1,950 | 0 | 216,950 | 215 K to 217 K (+0.91 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 |
Page: 1